Amgen Inc.
AMGN
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell counā¦ read more
Healthcare
Drug ManufacturersāGeneral
42 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$340.08
Price-0.02%
-$0.08
1Y
Price
Market Cap
$183.127b
Large
Price/Earnings 3y Avg5y Avg
25.8x
Premium
Premium
Financials Overview
Key metrics over the past few years+61.9%
EBITDA Margin+33.7%
Net Profit Margin+44.5%
Free Cash Flow MarginRevenue
$35.959b
+7.6%
1y CAGR+11.1%
3y CAGR+8.6%
5y CAGREarnings
$7.005b
+71.3%
1y CAGR+11.6%
3y CAGR+11.5%
5y CAGREPS
$12.94
+71.2%
1y CAGR+11.6%
3y CAGR+13.2%
5y CAGRBook Value
$9.619b
$90.141b
Assets$80.522b
Liabilities$54.587b
DebtDebt to Assets
60.6%
3.3x
Debt to EBITDAFree Cash Flow
$11.539b
+11.0%
1y CAGR+12.0%
3y CAGR+10.2%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company